ProFound Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
46
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$20M
- Investors
-
5
ProFound Therapeutics General Information
Description
Developer of a novel therapeutic target discovery platform designed to make a profound impact on human health. The company's platform uses protein detection technologies, computational methods, and experimental testing to identify proteins and study their roles in health and disease to discover previously unidentified human proteins, enabling biopharmaceutical researchers to discover new drug targets and develop treatments across multiple disease areas.
Contact Information
Website
www.profoundtx.comCorporate Office
- 55 Cambridge Parkway
- Suite 800E
- Cambridge, MA 02142
- United States
Corporate Office
- 55 Cambridge Parkway
- Suite 800E
- Cambridge, MA 02142
- United States
ProFound Therapeutics Timeline
ProFound Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 27-Aug-2026 | $20M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series B) | 06-Feb-2025 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A2) | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A1) | 31-Aug-2022 | $12.7M | $87.7M | Completed | Generating Revenue | |
| 1. Early Stage VC | 26-May-2022 | $75M | $75M | Completed | Generating Revenue |
ProFound Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 6,382,445 | $0.001000 | $2 | $2 | $2 | 10.5% | ||
| Series A | 12,350,110 | $0.001000 | $1 | $1 | 1x | $1 | 20.32% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
ProFound Therapeutics Comparisons
Industry
Financing
Details
ProFound Therapeutics Competitors (1)
One of ProFound Therapeutics’s competitors is Nautilus Biotechnology, a Formerly VC-backed company based in Seattle, WA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nautilus Biotechnology | Formerly VC-backed | Seattle, WA |
ProFound Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ProFound Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ProFound Therapeutics Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gates Foundation | Not-For-Profit Venture Capital | Minority | ||
| Modi Ventures | Venture Capital | Minority | ||
| Samsung Venture Investment | Corporate Venture Capital | Minority | ||
| Notley Ventures | Impact Investing | Minority | ||
| Flagship Pioneering | Venture Capital | Minority |
ProFound Therapeutics FAQs
-
When was ProFound Therapeutics founded?
ProFound Therapeutics was founded in 2020.
-
Where is ProFound Therapeutics headquartered?
ProFound Therapeutics is headquartered in Cambridge, MA.
-
What is the size of ProFound Therapeutics?
ProFound Therapeutics has 46 total employees.
-
What industry is ProFound Therapeutics in?
ProFound Therapeutics’s primary industry is Drug Discovery.
-
Is ProFound Therapeutics a private or public company?
ProFound Therapeutics is a Private company.
-
What is ProFound Therapeutics’s current revenue?
The current revenue for ProFound Therapeutics is .
-
How much funding has ProFound Therapeutics raised over time?
ProFound Therapeutics has raised $183M.
-
Who are ProFound Therapeutics’s investors?
Gates Foundation, Modi Ventures, Samsung Venture Investment, Notley Ventures, and Flagship Pioneering have invested in ProFound Therapeutics.
-
Who are ProFound Therapeutics’s competitors?
Nautilus Biotechnology is a competitor of ProFound Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
